378 related articles for article (PubMed ID: 22147145)
21. Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study.
de Pablos-Velasco P; Gonzalez-Albarran O; Estopiñan V; Khanbhai A
J Hum Hypertens; 2007 Aug; 21(8):664-72. PubMed ID: 17460709
[TBL] [Abstract][Full Text] [Related]
22. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure control in patients initiating antihypertensive therapy.
Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
[TBL] [Abstract][Full Text] [Related]
24. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
25. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
26. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
27. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L
Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
[TBL] [Abstract][Full Text] [Related]
28. Ethnic differences in antihypertensive medication use in the elderly.
Raji MA; Kuo YF; Salazar JA; Satish S; Goodwin JS
Ann Pharmacother; 2004 Feb; 38(2):209-14. PubMed ID: 14742752
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
30. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006.
Ebrahimi M; Mansournia MA; Haghdoost AA; Abazari A; Alaeddini F; Mirzazadeh A; Yunesian M
J Hypertens; 2010 Aug; 28(8):1620-9. PubMed ID: 20647858
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
32. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
[TBL] [Abstract][Full Text] [Related]
33. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
34. Patient race/ethnicity and shared medical record use among diabetes patients.
Lyles CR; Harris LT; Jordan L; Grothaus L; Wehnes L; Reid RJ; Ralston JD
Med Care; 2012 May; 50(5):434-40. PubMed ID: 22354209
[TBL] [Abstract][Full Text] [Related]
35. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.
Gu Q; Burt VL; Dillon CF; Yoon S
Circulation; 2012 Oct; 126(17):2105-14. PubMed ID: 23091084
[TBL] [Abstract][Full Text] [Related]
36. Contemporary Management and Control of Uncomplicated Hypertension in Canada: Insight From the Primary Care Audit of Global Risk Management (PARADIGM) Study.
Gupta M; Szmitko P; Singh N; Tsigoulis M; Kajil M; Stone J
Can J Cardiol; 2015 May; 31(5):664-70. PubMed ID: 25936492
[TBL] [Abstract][Full Text] [Related]
37. Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006.
Ostchega Y; Yoon SS; Hughes J; Louis T
NCHS Data Brief; 2008 Jan; (3):1-8. PubMed ID: 19389317
[TBL] [Abstract][Full Text] [Related]
38. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.
Wong MC; Lau RK; Jiang JY; Griffiths SM
J Clin Pharm Ther; 2012 Jun; 37(3):335-41. PubMed ID: 22023456
[TBL] [Abstract][Full Text] [Related]
39. Determinants of blood pressure treatment and control in obese people: evidence from the general population.
Czernichow S; Castetbon K; Salanave B; Vernay M; Barry Y; Batty GD; Hercberg S; Blacher J
J Hypertens; 2012 Dec; 30(12):2338-44. PubMed ID: 23032140
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009.
Gee ME; Janssen I; Pickett W; McAlister FA; Bancej CM; Joffres M; Johansen H; Campbell NR
Can J Cardiol; 2012 May; 28(3):367-74. PubMed ID: 22281410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
